Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Boehringer Ingelheim Pharmaceuticals, Inc. in Australia and New Zealand seeks a Head of Clinical Development & Operations (CD&O) to lead the local CD&O team within the ASKAN ROPU.
You will drive execution of clinical trials for the country, ensuring scientific, regulatory and commercial needs are met while identifying opportunities for competitive advantage. You will oversee talent, maintain high-performance standards, and collaborate with regional leadership to align CD&O strategy and leverage
Reporting to the head of Medcine of Australia & New Zealand, an exciting opportunity has arisen to come and join our high performing medical team!
Your role as the Head of Clinical Development & Operations (CD&O), Australia and New Zealand, will be to lead the local CD&O team which is part of the Regional Operating Unit (ROPU) ASKAN. The Head of CD&O is responsible for the execution and delivery of the clinical trials allocated to the country that meet pipeline commitments, specific scientific medical, regulatory, and commercial needs.
An important part of this role is you will also be tasked to identify opportunities that create competitive advantage and drives clinical development excellence and will be responsible for the performance in the respective country.
Reporting to the head of Medcine of Australia & New Zealand, an exciting opportunity has arisen to come and join our high performing medical team!
Your role as the Head of Clinical Development & Operations (CD&O), Australia and New Zealand, will be to lead the local CD&O team which is part of the Regional Operating Unit (ROPU) ASKAN. The Head of CD&O is responsible for the execution and delivery of the clinical trials allocated to the country that meet pipeline commitments, specific scientific medical, regulatory, and commercial needs.
An important part of this role is you will also be tasked to identify opportunities that create competitive advantage and drives clinical development excellence and will be responsible for the performance in the respective country.